Followers | 13 |
Posts | 462 |
Boards Moderated | 0 |
Alias Born | 09/21/2017 |
Friday, October 22, 2021 5:19:00 AM
They fail to understand (or pretend not to) that NWBO has only one shot at goal and if they unblind too prematurely or apply for approval without incontrovertible evidence of efficacy, the chance for DCVax-L use would be lost! What if the RAs ask for further studies? The company would be bk’d or be close to it! How many more deaths would occur while other therapies are being trialled? What about the “yet to be diagnosed” GBM patients? However, these shareholders just move on to the next “shiny stone”!
What about the lost potential of DCVax Direct?
The impatience of these “wanna get rich instantly” shareholders, who want results NOW (without NWBO lining up the ducks) are handing the BPs an opportunity to pick up DCVax tech at pennies to the dollar!
This will allow BPs to “milk” their toxic chemo till the end of its patent and then only then will they introduce a “new and novel” therapy i.e DCVax!
I’ve been in this investment for nearly 8 years and am also getting long in the tooth but hey, know what and why you invested in NWBO in the first place!
GLTALs
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM